Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,057–2,064 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Immuron Limited Travelan (IMM-124E) Gut Health During Travel Phase 2 Ongoing Oral Gastroenterology
Immuron Limited IMM-529 C. difficile infection Phase 2 IND Clearance Oral Antibiotic
Immuron Limited Travelan - (CHIM) Enterotoxigenic Escherichia coli (ETEC) Phase 2 Data Released Oral Gastroenterology
Immuron Limited Campylobacter ETEC Therapeutic Campylobacteriosis Phase 2 Oral N/A
Immuron Limited Campylobacter ETEC Therapeutic Campylobacter and enterotoxigenic E.coli (ETEC) infections Phase 2 Oral Antibiotic
Immutep Limited Eftilagimod alpha and KEYTRUDA (pembrolizumab) - (TACTI-002/KEYNOTE-798) Non-small cell lung cancer; Head and neck cancer Phase 2 Ongoing Intravenous Oncology
Immutep Limited Eftilagimod alpha - (EAT COVID) COVID-19 Phase 2 Subcutaneous COVID-19
Immutep Limited GSK2831781 Ulcerative Colitis Phase 2 Trial Discontinued Intravenous Gastroenterology